Trial Profile
Confirmatory Study of FYU-981 for Hyperuricemia With or Without Gout (Phase II (IIb) Study)
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 22 Nov 2021
Price :
$35
*
At a glance
- Drugs Dotinurad (Primary)
- Indications Hyperuricaemia
- Focus Pharmacodynamics
- Sponsors Fuji Yakuhin
- 15 Nov 2021 Results of systematic review and meta-analysis of randomized controlled trials (NCT02416167, NCT03100318, NCT03372200 ) were published in the International Journal of Clinical Pharmacology and Therapeutics.
- 13 Feb 2017 Status changed from active, no longer recruiting to completed.
- 19 May 2015 Status changed from not yet recruiting to recruiting, according to to ClinicalTrials.gov record.